Imaging, biodistribution and efficacy evaluation of ¹⁸⁸Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model

References

• Bernal P, Raoul JL, Vidmar G, Sereegotov E, Sundram FX, Kumar A, Jeong JM, Pusuwan P, Divgi C, Zanzonico P, et al. 2007. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study. Int J Radiat Oncol Biol Phys. 69:1448–1455.
   PubMed Web of Science ®Google Scholar
• Bruix J, Llovet JM. 2009. Major achievements in hepatocellular carcinoma. Lancet. 373:614–616.
   PubMed Web of Science ®Google Scholar
• Buendia MA, Neuveut C. 2015. Hepatocellular carcinoma. Cold Spring Harb Perspect Med. 5:a021444.
   Web of Science ®Google Scholar
• Chang YJ, Chang CH, Yu CY, Chang TJ, Chen LC, Chen MH, Lee TW, Ting G. 2010. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Nucl Med Biol. 37:95–104.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, Group R-HS. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 295:65–73.
   PubMed Web of Science ®Google Scholar
• Chen LC, Wu YH, Liu IH, Ho CL, Lee WC, Chang CH, Lan KL, Ting G, Lee TW, Shien JH. 2012. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model. Nucl Med Biol. 39:35–43.
   PubMed Web of Science ®Google Scholar
• Colombo M, Sangiovanni A. 2015. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 35(Suppl 1):129–138.
   PubMed Web of Science ®Google Scholar
• Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Arico D, Mallia A, De Cicco C, Pedroli G, Paganelli G. 2008. Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging. 35:2088–2096.
   PubMed Web of Science ®Google Scholar
• Culler MD, Oberg K, Arnold R, Krenning EP, Sevilla I, Diaz JA. 2011. Somatostatin analogs for the treatment of neuroendocrine tumors. Cancer Metastasis Rev. 30(Suppl 1):9–17.
   PubMed Web of Science ®Google Scholar
• de Kemp RA, Epstein FH, Catana C, Tsui BM, Ritman EL. 2010. Small-animal molecular imaging methods. J Nucl Med. 51(Suppl.1):18S–32S.
   PubMed Web of Science ®Google Scholar
• Druce MR, Lewington V, Grossman AB. 2010. Targeted radionuclide therapy for neuroendocrine tumours: principles and application. Neuroendocrinology. 91:1–15.
   PubMed Web of Science ®Google Scholar
• Elschot M, Nijsen JF, Lam MG, Smits ML, Prince JF, Viergever MA, van den Bosch MA, Zonnenberg BA, de Jong HW. 2014. (99m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with (166)Ho-microspheres. Eur J Nucl Med Mol Imaging. 41:1965–1975.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2014. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Garin E, Denizot B, Roux J, Noiret N, Lepareur N, Moreau M, Mesba H, Laurent JF, Herry JY, Bourguet P, et al. 2005. Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat. Lab Anim. 39:314–320.
   PubMed Web of Science ®Google Scholar
• Gil-Alzugaray B, Chopitea A, Inarrairaegui M, Bilbao JI, Rodriguez-Fraile M, Rodriguez J, Benito A, Dominguez I, D’Avola D, Herrero JI, et al. 2013. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 57:1078–1087.
   PubMed Web of Science ®Google Scholar
• Graham KC, Wirtzfeld LA, MacKenzie LT, Postenka CO, Groom AC, MacDonald IC, Fenster A, Lacefield JC, Chambers AF. 2005. Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res. 65:5231–5237.
   PubMed Web of Science ®Google Scholar
• Lambert B, Bacher K, Defreyne L, Gemmel F, Van Vlierberghe H, Jeong JM, Dierckx RA, Van de Wiele C, Thierens H, De Vos F. 2005. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med. 46:60–66.
   PubMed Web of Science ®Google Scholar
• Lambert B, Van de Wiele C. 2005. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 32:980–989.
   PubMed Web of Science ®Google Scholar
• Leung WT, Lau WY, Ho SK, Chan M, Leung NW, Lin J, Metreweli C, Johnson PJ, Li AK. 1994. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. J Nucl Med. 35:70–73.
   PubMed Web of Science ®Google Scholar
• Liepe K, Brogsitter C, Leonhard J, Wunderlich G, Hliscs R, Pinkert J, Folprecht G, Kotzerke J. 2007. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization. Jpn J Clin Oncol. 37:942–950.
   PubMed Web of Science ®Google Scholar
• Liepe K, Kotzerke J, Lambert B. 2005. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases. J Nucl Med. 46:1407–1408.
   PubMed Web of Science ®Google Scholar
• Lin SB, Wu LC, Huang SL, Hsu HL, Hsieh SH, Chi CW, Au LC. 2000. In vitro and in vivo suppression of growth of rat liver epithelial tumor cells by antisense oligonucleotide against protein kinase C-alpha. J Hepatol. 33:601–608.
   PubMed Web of Science ®Google Scholar
• Murthy R, Kamat P, Nunez R, Salem R. 2008. Radioembolization of yttrium-90 microspheres for hepatic malignancy. Semin Intervent Radiol. 25:48–57.
   PubMedGoogle Scholar
• Neves M, Kling A, Oliveira A. 2005. Radionuclides used for therapy and suggestion for new candidates. J Radioanal Nucl Chem. 266:377–384.
   Web of Science ®Google Scholar
• Ni HC, Yu CY, Chen SJ, Chen LC, Lin CH, Lee WC, Chuang CH, Ho CL, Chang CH, Lee TW. 2015. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats. Appl Radiat Isot. 99:117–121.
   PubMed Web of Science ®Google Scholar
• Nowicki ML, Cwikla JB, Sankowski AJ, Shcherbinin S, Grimmes J, Celler A, Buscombe JR, Bator A, Pech M, Mikolajczak R, et al. 2014. Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. Med Sci Monit. 20:1353–1362.
   PubMed Web of Science ®Google Scholar
• Okuda K. 2000. Hepatocellular carcinoma. J Hepatol. 32:225–237.
   PubMed Web of Science ®Google Scholar
• Peker A, Cicek O, Soydal C, Kucuk NO, Bilgic S. 2015. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases. Diagn Interv Radiol. 21:54–59.
   PubMed Web of Science ®Google Scholar
• Pillai MR, Dash A, Knapp FF Jr. 2012. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications. Curr Radiopharm. 5:228–243.
   PubMedGoogle Scholar
• Price TJ, Townsend A. 2008. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg. 143:313–314.
   PubMedGoogle Scholar
• Salem R, Lewandowski RJ. 2013. Chemoembolization and radioembolization for hepatocellular carcinoma. Clin Gastroenterol Hepatol. 11:604–611.
   PubMed Web of Science ®Google Scholar
• Ting G, Chang CH, Wang HE, Lee TW. 2010. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J Biomed Biotechnol. 2010:953537.
   PubMedGoogle Scholar
• Wirtzfeld LA, Wu G, Bygrave M, Yamasaki Y, Sakai H, Moussa M, Izawa JI, Downey DB, Greenberg NM, Fenster A, et al. 2005. A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model. Cancer Res. 65:6337–6345.
   PubMed Web of Science ®Google Scholar
• Wunderlich G, Drews A, Kotzerke J. 2005a. A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine. Appl Radiat Isot. 62:915–918.
   PubMed Web of Science ®Google Scholar
• Wunderlich G, Pinkert J, Stintz M, Kotzerke J. 2005b. Labeling and biodistribution of different particle materials for radioembolization therapy with 188Re. Appl Radiat Isot. 62:745–750.
   PubMed Web of Science ®Google Scholar
• Wunderlich G, Schiller E, Bergmann R, Pietzsch HJ. 2010. Comparison of the stability of Y-90-, Lu-177- and Ga-68-labeled human serum albumin microspheres (DOTA-HSAM). Nucl Med Biol. 37:861–867.
   PubMed Web of Science ®Google Scholar